CLEO Diagnostics LtdASX: COV

Quarterly activities and cashflow report

· Issued by CLEO Diagnostics Ltd via ASX

Filed with ASX ·

ASX Announcement September 2026 Quarterly Activities Report Highlights ? Analytical Validation in progress following receipt of ?rst batch of test kits ? Statement of Work executed with CLIA-certi?ed U.S. laboratory, Asuragen, to undertake the pivotal Clinical Validation testing program ? Screening...

View Attachment

6ix is reading this filing.

CLEO Diagnostics Ltd on 6ix

Earlier from CLEO Diagnostics

All CLEO Diagnostics news releases